SEC Form 4 · accession 0001237899-15-000034
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas S McCorkle
Officer — VP Controller and Asst Treasur
Period of report
May 22, 2015
Accepted (ET)
May 26, 2015 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2015 | M | 13,000 | $179.13 | A | 17,481 | D | |
| Common StockF1 | May 22, 2015 | S | 13,000 | $515.60 | D | 4,481 | D | |
| Common Stock | May 22, 2015 | M | 464 | $30.63 | A | 4,945 | D | |
| Common Stock | holding | — | — | — | 4,129 | I | By 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F2 | $30.63 | May 22, 2015 | M | 464 | D | — | Dec 14, 2020 | Common Stock | 464 | 0 | D |
| Non-Qualified Stock Option (right to buy)F3 | $179.13 | May 22, 2015 | M | 13,000 | D | — | Dec 14, 2022 | Common Stock | 13,000 | 13,000 | D |
Explanation of responses
- F1Represents volume-weighted average price of sales of 13,000 shares of Company stock on May 22, 2015 at prices ranging from $515.18 to $515.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 22, 2015 at each separate price.
- F2The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- F3The stock option award vests in four equal annual installments, commencing one year after the date of grant.